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Abstract
Background: Mass spectrometry protein profiling is a promising tool for biomarker discovery in
clinical proteomics. However, the development of a reliable approach for the separation of protein
signals from noise is required. In this paper, LIMPIC, a computational method for the detection of
protein peaks from linear-mode MALDI-TOF data is proposed. LIMPIC is based on novel
techniques for background noise reduction and baseline removal. Peak detection is performed
considering the presence of a non-homogeneous noise level in the mass spectrum. A comparison
of the peaks collected from multiple spectra is used to classify them on the basis of a detection rate
parameter, and hence to separate the protein signals from other disturbances.
Results:  LIMPIC preprocessing proves to be superior than other classical preprocessing
techniques, allowing for a reliable decomposition of the background noise and the baseline drift
from the MALDI-TOF mass spectra. It provides lower coefficient of variation associated with the
peak intensity, improving the reliability of the information that can be extracted from single spectra.
Our results show that LIMPIC peak-picking is effective even in low protein concentration regimes.
The analytical comparison with commercial and freeware peak-picking algorithms demonstrates its
superior performances in terms of sensitivity and specificity, both on in-vitro purified protein
samples and human plasma samples.
Conclusion: The quantitative information on the peak intensity extracted with LIMPIC could be
used for the recognition of significant protein profiles by means of advanced statistic tools: LIMPIC
might be valuable in the perspective of biomarker discovery.
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Background
The research in protein biomarkers discovery is one of the
fundamental topics in clinical proteomics in order to pos-
sibly improve both diagnosis and prognosis of a wide
variety of disease states [1]. Mass spectrometry has proved
to be the most promising tool in the perspective of
biomarker identification [2,3]: it allows measuring the
mass of ionized molecules, hence making it possible to
analyze proteins in small concentrations and in a short
time. In particular, excellent resolution and good mass
accuracy combined with high sample throughput can be
achieved with matrix-assisted laser desorption/ionization
time-of-flight (MALDI-TOF) mass spectrometry [4,5]. The
MALDI-TOF device produces signals that correspond to
the different flight times of the analyzed proteins, which
are ionized by means of a high energy laser beam and
accelerated with an electric field: the ions, detected at the
end of the tube, can be separated on the basis of their
mass/charge ratio (m/z). The acquired spectra always
present complex features, because the protein signals,
characterized by "true" peaks in the mass spectrum, can be
contaminated by several chemical and/or physical proc-
esses of the measurement procedure [6,7]. Two different
kinds of disturbance can be revealed in the spectra: base-
line drift and background noise. The baseline is the trend
of the signal that would be generated by the mass spec-
trometer if no material was introduced into it. The back-
ground noise is a signal produced by electronic
disturbances and fragments of material, with rapid fluctu-
ations randomly varying over small mass ranges. As a con-
sequence, a very sensitive and accurate peak-detection
method, able to correctly separate "true" protein peaks
from noise, is required [2]. Several methods using analyt-
ical rules, template matching and wavelet techniques have
been proposed in the literature [6,8-11]. However, the
problem of the detection of noise peaks as signals still
remains a critical issue [12].
In this work, we propose a computational method for the
detection of protein peaks from multiple MALDI-TOF-MS
data, named LIMPIC (linear MALDI-TOF-MS peak indica-
tion and classification). Its major improvement is a new
procedure for decomposing a MALDI-TOF mass spectrum
into signal, baseline and noise. Subsequently, LIMPIC
estimates an non-uniform residual noise level from proc-
essed spectra, and it detects protein signals by finding
peaks that have significantly high signal-to-noise ratio.
The peak lists generated from the single spectra are then
compared, and a classification between molecular signal
peaks and noise is performed on the basis of a detection
rate parameter. In-vitro purified protein samples and
human plasma samples were used for the validation of
LIMPIC: in both conditions, the proposed method
showed a significant accuracy in the detection of the pro-
tein signals, and it was able to provide a superior sensitiv-
ity and specificity than two well-established commercial
algorithms, APEX and CENTROID, and a freely available
algorithm, CROMWELL.
Results
The LIMPIC method was developed for the detection of
consistent protein peaks, starting from a set of calibrated
mass spectra. It was implemented in MATLAB, and is pro-
vided as Additional File 1. A schematic overview of its
processing and analysis steps is given in Figure 1. Each
mass spectrum is preprocessed with smoothing and base-
line removal. The smoothing is performed by means of a
Kaiser digital filter working with a moving window [13];
the baseline removal is accomplished with the subtraction
of a signal trend, estimated after the elimination of the
most significant peaks in the mass spectrum. The detec-
tion of protein peaks in the single spectra is performed by
finding all the local maxima, and eliminating those with
intensity lower than a non-uniform threshold, propor-
tional to the noise level [14]. The peaks detected for the
single spectra are clustered on the basis of their m/z posi-
tion, and then classified as protein or noise peaks on the
basis of their consistency across the spectra [15,16].
The validation of the proposed method for the separation
of MALDI-TOF-MS signals from noise regarded two
aspects: the effectiveness of signal processing and the
detection of reliable protein peaks. For this purpose, we
used mass spectra from in-vitro purified protein mixtures
for testing LIMPIC under controlled conditions, and
human plasma samples for validating it in the perspective
of clinical applications. The two sets of MALDI-TOF mass
spectra are respectively provided as Additional Files 2 and
3. In this study, we also compared the outcomes of
LIMPIC with those of two commercial algorithms, APEX
and CENTROID (implemented in the software package
FlexAnalysis by Bruker Daltonics) [17,18], and of a
recently released freeware algorithm, CROMWELL, cre-
ated by the Texas University bioinformatics group [10,19].
An example of MALDI-TOF data from plasma samples,
noticeably contaminated by baseline drift and back-
ground noise, is illustrated in Figure 2. With regard to
spectrum denoising, we analyzed the performances of Kai-
ser filter with different window lengths, in order to find
the general criteria for setting this parameter. In fact, small
window lengths might result in an insufficient denoising,
whereas large ones might distort the "true" signal. As
shown in Figure 3, we explored 4 different parameter set-
tings, with window length ranging between 10 and 40
data points. Analyzing the subtracted noise, we found that
its amplitude increased with the window length; however,
we observed that the smoothing using the two larger win-
dow lengths produced signal distortions, evidenced by a
peaked signal distribution exactly where peaks occurred inBMC Bioinformatics 2007, 8:101 http://www.biomedcentral.com/1471-2105/8/101
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the mass spectrum. Consequently, we decided to set this
parameter equal to 20, thus covering a range of 5 Da in the
mass spectrum. The performances of Kaiser filter in terms
of data smoothing were compared with those of Savitzky-
Golay filter [20], the solution generally adopted in FlexA-
nalysis with APEX and CENTROID, and Wavelet filter
[10], the smoothing technique used in CROMWELL. For
Savitzky-Golay filter, that is also based on a moving win-
dow, we used the same window length as for Kaiser filter,
whereas for Wavelet filter we adopted the parameters sug-
gested by the CROMWELL research group. As illustrated
in Figure 4, Wavelet filter provides very different out-
comes with respect to the two moving-window filters: it
was minimally influenced by the presence of peaks in the
mass spectrum, but it did not seem to properly reconstruct
noise structure at the high end of the studied mass range.
We measured the similarity of the noise structures with
respect to Gaussian noise by means of two statistical
parameters: skewness and kurtosis. Surprisingly, Wavelet
filters presented a significant value of skewness, that is
related to the presence of an asymmetrical noise distribu-
tion. Conversely, Savitzky-Golay and Kaiser filters showed
LIMPIC architecture Figure 1
LIMPIC architecture. Schematic representation of the LIMPIC software. Through its processing and analysis steps, LIMPIC 
retrieves information from a set of calibrated MALDI-TOF mass spectra, and provides a list of "true" molecular signal peaks.BMC Bioinformatics 2007, 8:101 http://www.biomedcentral.com/1471-2105/8/101
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noise structures consistent with respect to the mass spec-
trum, and more similar to Gaussian noise, with relatively
low values of skewness and kurtosis.
With regard to baseline removal, we compared the peak-
elimination method used in LIMPIC with the classical
method based on minimum value interpolation [6,10],
used by APEX, CENTROID and CROMWELL. The two
estimates of the baseline drift are superimposed in Figure
5. The most evident difference is that the LIMPIC baseline
can locally increase, for example when large and overlap-
ping peaks are present in the spectrum.
A qualitative comparison referring to the mass spectrum
shown in Figure 2, before and after smoothing and base-
line subtraction, is provided in Figure 6 for LIMPIC, APEX,
CENTROID and CROMWELL processing. Furthermore,
the reliability of intensity reconstruction was assessed
using mass spectra acquired from in-vitro purified protein
mixtures of equine myoglobin and cytochrome C. This
analysis was carried out at 6 different concentrations of
cytochrome C, ranging between 2.5 and 50 fmol. For each
concentration, the coefficient of variation was calculated
on 5 replicate spectra for the peak corresponding to the
single-protonated molecular ion of cytochrome C (Table
1). LIMPIC processing provided results that were compa-
rable to APEX, CENTROID and CROMWELL above 10
fmol, whereas it allowed a more reliable estimate of signal
intensity at lower protein concentrations.
In particular, CROMWELL produced null intensity for the
cytochrome C peak at 2.5 fmol, including it in the sub-
tracted noise, and APEX and CENTROID showed a coeffi-
cient of variation equal to 24%, which might be ascribed
to a residual noise level comparable to the peak intensity.
In this case, the coefficient of variation after LIMPIC
processing was equal to 8%.
Using the same in-vitro protein mass spectra, the peak
detection sensitivity of LIMPIC was compared with that of
APEX, CENTROID and CROMWELL. The latter does not
need parameter tuning; conversely, a number of input
parameters are required by the two commercial algo-
rithms. Therefore, we adopted the typical parameters used
in our lab: SNR = 3 and peak width 0.75 Da for APEX; SNR
= 3, peak width 0.75 Da and percent height 80% for CEN-
TROID. In order to have comparable results, the peaks
detected with the commercial algorithms and with
CROMWELL from the replicate spectra were clustered as
for LIMPIC. We also classified the peaks on the basis of a
parameter named peak detection rate (PDR), expressed by
the ratio between the number of spectra containing the
considered peak and the total number of analyzed spectra.
As shown in detail in Table 1, only LIMPIC was capable to
reveal the cytochrome C peak in case of low protein con-
centration regimes (< 10 fmol), when ionic competition
processes in the mass spectra produced a loss of linearity
between the protein abundance and the related peak
intensity. The comparative results of the peak-picking
algorithms for all peaks are summarized in Table 2. The
correct identification of the protein peaks was generally
accomplished with LIMPIC for all the acquired signals,
with no false negatives and only one false positive among
the 54 detected peaks. On the other hand, a large number
of incorrect peaks was produced by APEX, CENTROID
and CROMWELL. These results were confirmed by those
obtained with plasma spectra, for which an example of
the peaks detected by the four methods from a single spec-
trum is provided in Figure 7. When comparing the peaks
from the single spectrum with those obtained from the
other plasma spectra, we found that only a part of them is
consistent. In Figure 8 we provide an example of the
LIMPIC classification, performed for the same peaks
shown in Figure 7, using a minimum PDR equal to 0.5.
Analytical results about peak masses and peak intensities
for the group of plasma samples are summarized in a
spreadsheet, which has been provided as Additional File
4. We grouped the 4382 peaks detected among all the
MALDI-TOF-MS signals into 1581 peak classes. This
allowed selecting the most reliable peaks, because only
the ones that are robustly found across spectra were
retained. Using a minimum PDR equal to 0.5, 62 out of
the 1581 peak classes were selected (Figure 9). In order to
determine whether the selected peaks could be used for
quantitative studies, the SNR values were analyzed. In par-
ticular, the condition SNR > 10 was fulfilled for all the 62
peaks, as illustrated in Figure 9.
Using the selection criterion based on the PDR value, it
was also possible to measure the hit-rate, defined as the
ratio between the number of "true" peak classes and the
average number of the peaks revealed in the single spectra:
the larger this ratio the better the performances of the
peak-picking method. According to this parameter, a
larger number of consistent peaks were generally detected
with LIMPIC, confirming the superior reliability of this
method for mass spectra from both protein mixtures and
plasma samples (Table 3).
Moreover, with regard to the classification of peaks from
plasma mass spectra, we analyzed the PDR distribution, in
order to obtain valuable information regarding the
method sensitivity in the separation of protein and noise
peaks. As it was impossible to accurately define the pres-
ence of a defined set of protein peaks, the detected peaks
were compared with a given list of 68 peaks that corre-
spond to proteins classified in the Human Plasma Pro-
teome Project (HPPP) database [21] which can be
revealed by MALDI-TOF mass spectrometry in the m/zBMC Bioinformatics 2007, 8:101 http://www.biomedcentral.com/1471-2105/8/101
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range 5–20 kDa [22]. The complete list of the proteins
considered for this analysis can be found in Additional
File 5. A ROC curve was calculated for LIMPIC, APEX,
CENTROID and CROMWELL, varying the minimum PDR
used for the peak classification (Figure 10). The results
demonstrated that a larger accuracy can be achieved with
LIMPIC; in particular, no false positives were obtained by
setting minimum PDR to 0.6, whereas the best perform-
ances in terms of sensitivity and specificity were attained
by setting minimum PDR to 0.4.
Discussion
We presented a reliable automated tool for signal denois-
ing and peak detection in MALDI-TOF-MS data. In con-
trast to many established approaches to this problem [6,8-
11], the proposed method was particularly designed to
work properly even on very low intensity peaks. LIMPIC
processing reduced the disturbances that partially hid the
true signal in the mass spectrum. In particular, the
smoothing algorithm permitted the reduction of the back-
ground noise without any noticeable distortion of the true
signal, and it seemed to be more effective than Savitzky-
Golay and Wavelet filters with MALDI-TOF-MS data.
Moreover, the LIMPIC baseline correction was able to
MALDI-TOF-MS spectrum from a human plasma sample Figure 2
MALDI-TOF-MS spectrum from a human plasma sample. Example of raw MALDI-TOF mass spectrum acquired from 
human plasma, showing the presence of background noise and baseline drift.BMC Bioinformatics 2007, 8:101 http://www.biomedcentral.com/1471-2105/8/101
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work with all kinds of spectra, even with those character-
ized by a non-increasing baseline drift, for which the
standard method based on fitting a monotone minimum
curve might be unsuccessful [10]. In addition, the coeffi-
cient of variation obtained with LIMPIC with in-vitro pro-
tein mixtures at low concentrations proved the efficacy of
the preprocessing steps, and also the reliability of the
quantitative information that could be extracted from sin-
gle peaks. According to the method proposed by Yasui [8],
the positions of the peaks in the mass spectrum were
determined on the basis of the first derivative of the sig-
nal, whereas other techniques based on template match-
ing were considered unreliable, because the presence of
Analysis of Kaiser filter denoising Figure 3
Analysis of Kaiser filter denoising. The Kaiser filter performances can be appreciated from the difference between mass 
spectra before and after smoothing. The outcomes for the mass spectrum shown in Figure 2, referring to moving window 
length equal to 10, 20, 30 and 40 data points, are respectively presented in (a), (b), (c) and (d).BMC Bioinformatics 2007, 8:101 http://www.biomedcentral.com/1471-2105/8/101
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residual noise could corrupt the ideal peak shape and
could determine incorrect outcomes [23].
Given the significant consistency of noise level across
spectra, also after preprocessing, an alternative technique
for the reduction of false peak discovery was proposed in
the literature [15]. It is not based on data smoothing, but
on the determination of a proper non-uniform threshold,
in order to exclude intensities associated with the noise.
The noise level is calculated by means of the local stand-
ard deviation, considering data points with intensity
below the 90th percentile. As a result, this approach might
be inappropriate in case of spectra with a high number of
large-intensity peaks. Also our method takes into account
the presence of an uneven noise level, but in our opinion
it is suitable for a broader variety of mass spectra: it esti-
mates a non-uniform noise threshold on the basis of the
waveform properties, without making any assumptions
on the signal intensities.
Although the IUPAC guidelines suggest the use of the con-
dition s > 10σ to extract quantitative information on sig-
nal intensity [14], we found that the LIMPIC
configuration with s > 3σ still yields good performances,
allowing an accurate identification of weak peaks. How-
ever, in light of the findings of other research groups using
Smoothing performance comparison Figure 4
Smoothing performance comparison. The performances of several smoothing algorithms can be appreciated from the 
difference between mass spectra before and after smoothing. The outcomes obtained from Savitzky-Golay, Wavelet and Kaiser 
filters for the mass spectrum shown in Figure 2 are respectively illustrated in (a), (b) and (c).BMC Bioinformatics 2007, 8:101 http://www.biomedcentral.com/1471-2105/8/101
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different methods, it is clear that the number of peaks
detected in the single spectrum is not, by itself, a sufficient
measure of the peak-picking effectiveness [10]. Since we
matched the results obtained from replicate spectra, we
could also appraise the amount of peaks that, after the
comparison, were likely to be classified as noise peaks
[16]. The PDR analysis was aimed at obtaining an optimal
separation between protein signals from noise. In particu-
lar, the optimal cut-off value had to be properly chosen,
depending on the specific application: the selection of a
large value (e.g. PDR ≥ 0.6) increased the reliability of the
selected peaks, but simultaneously reduced the amount of
information that can be used for subsequent analyses.
When a relatively small value is chosen (e.g. PDR ≥ 0.4),
the probability of selecting "noise" peaks can be reduced
by also setting a threshold for the minimum acceptable
SNR. Nonetheless, the selection of peaks with SNR > 10
allows, in the perspective of biomarker discovery, to cate-
gorize the ones for which the associated intensity values
can be used for statistical tests.
Although the number of the detected peaks was generally
smaller for LIMPIC than for the commercial algorithms
APEX and CENTROID, and for the freeware algorithm
CROMWELL, the larger hit-rates of the proposed method
demonstrated that a more reliable selection of real protein
Baseline removal performance comparison Figure 5
Baseline removal performance comparison. The baseline drift estimated with the minimum-value interpolation method 
(APEX, CENTROID and CROMWELL processing) is compared with that of the peak-elimination method (LIMPIC processing).BMC Bioinformatics 2007, 8:101 http://www.biomedcentral.com/1471-2105/8/101
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signals can be accomplished. Therefore, the ROC curves
calculated for the four methods reveal that a superior sen-
sitivity and specificity can be obtained with LIMPIC, par-
ticularly when a low cut-off value was used for the PDR.
Conclusion
The discovery of protein profiles that can be ascribed to
each pathologic state and the classification of individual
proteins that compose them are key steps in the direction
of an early disease detection. The proposed method was
intended for the reliable detection of protein peaks using
average mass signals such as the one collected from linear
MALDI-TOF-MS instruments. In this case, data processing
is particularly difficult, because weak protein signals, rep-
resented by the "true" peaks in the acquired spectra, are
generally hidden by two disturbances: baseline drift and
background noise. We developed a novel technique for
mass spectrometric data denoising, and we showed that
the processed spectra can be jointly used for peak detec-
tion with high reliability and accuracy. The LIMPIC
method was properly designed in order to work correctly
also in case of very weak peaks. Moreover, the entire
processing procedures and algorithms can be modified
and tailored to the data produced by different acquisition
systems, allowing for a complete control, which is rarely
possible in commercial software solutions. With the
recent improvements in the MALDI-TOF technology, the
detection of protein peaks with a low coefficient of varia-
tion across measurements is becoming feasible; as a con-
sequence, the quantitative information on the peak
intensity extracted with our method could be used for the
recognition of significant protein profiles by means of
advanced statistic tools. We hope that the analytic strategy
presented here using mass spectrometric data will support
further advances for the discovery of novel disease-state
biomarkers.
Methods
MALDI-TOF-MS analysis
The MALDI-TOF mass spectra used in this study were
acquired from both human plasma samples and in-vitro
protein samples: the former were used to validate it in the
perspective of clinical applications, and the latter were
used to test the proposed method under controlled condi-
tions.
The human plasma samples were collected from 30
healthy subjects (age 28–40 years) who signed an
informed consent approved by the Local Ethical Commit-
tee. Equine myoglobin was dissolved in 0.1% trifluoro-
acetic acid (TFA) in deionized water and was used as
calibrator. Plasma sample preparation was performed
using ZipTip (Millipore) C4 tips with sinapinic acid [24].
The plasma samples (20 μl) were first acidified by addi-
tion of 5 μl 1% TFA before loading and preparation with
a sandwich layer method on MTP ground steel 384
(Bruker Daltonics). First, a sinapinic acid matrix seed layer
was created by depositing a droplet (0.5 μl) of a saturated
solution of sinapinic acid in 100% ethanol on the target.
The C4 resin was first activated by multiple washing with
10 μl of ACN/water (1:1) and then equilibrated by 0.1%
TFA. Thereafter the sample was trapped on the ZipTip
resin and washed with TFA 0.1%; finally the sample was
eluted from the resin using 2 μl of a saturated solution of
Denoising performances Figure 6
Denoising performances. The MALDI-TOF mass spec-
trum presented in Figure 2 is shown in the mass ranges 5–8 
kDa (a) and 14.75–17.75 kDa (b). The comparison between 
the noise subtracted by LIMPIC (c-d), APEX and CENTROID 
(e-f), and CROMWELL (g-h) in the same mass ranges is pre-
sented in the panes below.BMC Bioinformatics 2007, 8:101 http://www.biomedcentral.com/1471-2105/8/101
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sinapinic acid in 30/70 ACN/0.1% TFA and spotted
directly on MTP ground steel 384 (Bruker Daltonics).
The in-vitro protein samples were prepared at 6 different
dilutions, combining equine myoglobin and cytochrome
C. The first protein was maintained at the fixed concentra-
tion of 0.5 pmol/μl, whereas the concentration of the sec-
ond one was progressively reduced from 50 fmol/μl to 2.5
fmol/μl. First, 1 μl of each sample was acidified by the
addition of 9 μl 0.1% TFA. The resulting solution was
manually spotted with a ground steel onto 5 different
matrix droplets of the MALDI target using the sinapinic
acid sandwich method [24].
All MALDI analyses were performed with a MALDI-TOF
mass spectrometer Bruker-Daltonics Reflex IV, equipped
with a nitrogen laser (337 nm) [5]. The ion source and
flight tube were evacuated by turbo pumps to a pressure
lower than 6 × 10-7 mbar. All spectra were acquired in lin-
ear mode for a mass range of 5–20 kDa, at a voltage of 20,
17 and 9.60 kV for the first and second ion extraction
stage and lens, respectively. The laser power was modu-
lated between 20% and 40% in order to obtain less than
5 × 102 ion counts for a single acquisition run. Every single
acquisition run was composed by 100 laser pulses at 5 Hz;
multiple additions of single position acquisition run were
employed to obtain a minimal spectrum intensity scale of
5 × 103 ion counts. The m/z resolution of the resulting
mass spectra was decreasing from 0.33 to 0.70 Da from
the low end to the high end, respectively, of the consid-
ered mass range. In addition, peak resolution, based upon
the width of the peak at half the maximum intensity
(FWHM), was always larger than 1100 at the low end and
than 900 at the high end of the mass range.
Data processing and peak detection
To circumvent the problem of m/z shifts among spectra,
the signals were calibrated using the two main peaks
Table 1: Performance comparison of preprocessing methods.
Protein concentration 2.5 fmol 5 fmol 7.5 fmol 10 fmol 25 fmol 50 fmol
LIMPIC Average intensity 1.17 4.65 5.32 17.07 94.03 277.37
Standard deviation 0.10 0.39 0.61 2.70 14.01 42.48
Coefficient of variation 0.09 0.08 0.12 0.16 0.15 0.15
APEX & CENTROID Average intensity 1.31 5.36 6.05 14.94 88.48 283.08
Standard deviation 0.32 0.74 0.97 2.40 12.76 42.48
Coefficient of variation 0.24 0.14 0.16 0.16> 0.14 0.15
CROMWELL Average intensity 0 0 4.01 12.76 85.34 275.50
Standard deviation 0 0 1.52 2.95 13.79 48.49
Coefficient of variation - - 0.38 0.23 0.16 0.17
LIMPIC, APEX, CENTROID and CROMWELL preprocessing methods were evaluated from in-vitro protein spectra at different dilutions of 
cytochrome C. For each method, the average peak intensity, the standard deviation and the coefficient of variation are provided. The underlined 
values were manually obtained from the mass spectra, because the peak-picking algorithms did not allow to detect the peak.
Table 3: Hit-rate of peak-detection algorithms.
LIMPIC APEX CENTROID CROMWELL
In-vitro proteins Average number of detected peaks 16 42 62 50
Number of peak classes 11 21 27 23
Hit-rate 0.69 0.50 0.44 0.44
Human plasma Average number of detected peaks 146 291 283 172
Number of peak classes 62 84 76 60
Hit-rate 0.42 0.29 0.27 0.35
LIMPIC, APEX, CENTROID and CROMWELL methods were assessed with respect to the groups of mass spectra obtained from the in-vitro 
purified protein samples and human plasma samples, respectively. The performances were measured on the basis of a hit-rate parameter; the latter 
was obtained as a ratio between the number of peak classes, selected on the basis of a PDR larger than 0.5, and the average number of detected 
peaks.BMC Bioinformatics 2007, 8:101 http://www.biomedcentral.com/1471-2105/8/101
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derived from myoglobin ([M + H]+and [M + 2H]2+ ions of
myoglobin at m/z 16952 and 8476, respectively) as inter-
nal calibrants [7,25]. The spectra were also normalized
using the main peak intensity of the same protein. In
order to be suitable for data preprocessing, each linear-
mode MALDI-MS spectrum was converted to a text file
listing of 6 × 104 intensities versus m/z data points, spaced
0.25 Da from each other.
The classical approach for MALDI-TOF-MS data process-
ing consists in decomposing the acquired mass spectrum
r into three components: the true signal s, the baseline
drift  c, and the environmental noise σ. Consequently,
each mass spectrum can be schematically modeled by the
equation
r = s + c + σ   (1)
The true signal consists of a number of peaks at different
m/z values, the intensity of which of the same order of
magnitude as the background noise in same cases [6].
Consequently, a noise reduction technique was per-
formed at first: the signal-to-noise ratio (SNR) was
enhanced by using a smoothing procedure based on a Kai-
ser filter [13]. In short, a Kaiser filter is a Finite-Impulse-
Response (FIR) filter that approximates an ideal low-pass
filter, while attempting to minimize the ripples in the fre-
quency response caused by the signal truncation.
Given a set of input values w(t), a generic FIR filter gener-
ates an impulse response p(t) of the following form:
where l is an integer number that corresponds to the filter
order, and a0,..., al are proper coefficients. With regard to
the Kaiser filter theory, the design parameter l corresponds
to the length of the moving window used by the process-
ing algorithm. The smoothing parameter l can be tailored
to the specific mass spectrometric signals to be analyzed,
which might be characterized by different resolutions and
background noise levels.
The resulting spectrum was used to sequentially estimate
the baseline drift c and the non-uniform noise level σ. It
was divided into 100 signal blocks v1, ..., v100 each with a
150 Da width, and the blocks showing peaks were
selected on the basis of the kurtosis (fourth-order cumulant).
After centering a generic signal block v, the kurtosis kurt
could be computed as
kurt(v) = E{v4} - 3(E{v2})2   (3)
where E{￿} is the expectation operator [26].
The kurtosis is a measure of whether the data are peaked
or flat relative to a normal distribution: for a zero-mean
Gaussian random variable, kurtosis is null; for densities
peaked at zero, it is positive, and for flatter densities, it is
negative.
The categorization of signal blocks containing peaks,
accomplished with the condition kurt > 1, was necessary
pt awt n n
n
l
() ( ) =− ()
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Table 2: Performance comparison of peak-detection algorithms.
Protein concentration 2.5 fmol 5 fmol 7.5 fmol 10 fmol 25 fmol 50 fmol
Number of manually detected peak classes 7 7 10 8 10 11
LIMPIC Number of detected classes 8 7 10 8 10 11
Number of missed classes 0 0 0 0 0 0
Number of incorrect classes 1 0 0 0 0 0
APEX Number of detected classes 27 18 34 24 25 21
Number of missed classes 1 1 3 1 0 2
Number of incorrect classes 21 12 27 17 15 12
CENTROID Number of detected classes 40 52 48 24 25 27
Number of missed classes 1 1 1 0 0 0
Number of incorrect classes 34 46 39 16 15 16
CROMWELL Number of detected classes 14 15 14 16 21 24
Number of missed classes 3 3 6 2 3 4
Number of incorrect classes 10 11 10 10 14 17
LIMPIC, APEX, CENTROID and CROMWELL methods were assessed from in-vitro protein spectra at different cytochrome C dilutions, with 
respect to the number of detected peak classes, false negatives and false positives. Only the peak classes that could be found across replicate 
spectra with a peak detection rate (PDR) larger than 0.5 were considered for the analysis.BMC Bioinformatics 2007, 8:101 http://www.biomedcentral.com/1471-2105/8/101
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Peak-picking for a single mass spectrum Figure 7
Peak-picking for a single mass spectrum. Example of the peak-detection results for the four algorithms. For each of 
them, a plot of the mass spectrum shown in Figure 2 in the mass range 8.73–9.02 kDa is shown, along with the detected peaks, 
marked by red crosses.BMC Bioinformatics 2007, 8:101 http://www.biomedcentral.com/1471-2105/8/101
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because the peaks might alter the estimates of c and σ.
Consequently, the signal blocks containing peaks were
disregarded and the remaining blocks were used to create
a vector x = {x1, x2, ..., xN}, containing the m/z values cor-
responding to the central points of the intervals. The base-
line drift c was reconstructed using a linear interpolation
of the vector y = {y1, y2, ..., yN} with respect to the points
defined in x and generated from the average values of the
signal within the selected blocks. The baseline was sub-
tracted from the spectrum. A similar approach was used to
estimate the variable noise level σ, by means of the vector
w = {w1, w2, ..., wN}, containing the standard deviations of
the signal within the selected blocks. For each m/z value of
the mass spectrum, the noise level was used to calculate
the SNR, defined as the ratio between the estimated signal
intensity s and the estimated noise intensity σ, according
to the equation
Subsequently, the processed spectrum was analyzed for
the first step of the peak-picking procedure: if the point
intensity was the highest among its nearest ± f points, a
peak was detected in that position [8]. The number f could
be varied to best fit the specific resolution of the mass
SNR
rc
=
− ()
σ
4
LIMPIC classification of protein and noise peaks Figure 8
LIMPIC classification of protein and noise peaks. The same peaks detected by LIMPIC, shown in figure 7, classified after 
multiple-spectra comparison. The peaks with detection rate across spectra larger than or equal to 0.5, being considered pro-
tein peaks, are marked with green crosses, whereas the remaining peaks are assumed to be ascribed to noise and are marked 
with red crosses.BMC Bioinformatics 2007, 8:101 http://www.biomedcentral.com/1471-2105/8/101
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spectrometer; in this study, f was set equal to 2, in order to
cover a range of 0.5 Da. The second step of the peak-pick-
ing procedure was the elimination of the detected peaks
with a SNR lower than a preset threshold. In accordance
with the IUPAC guidelines [14], the limit of detection was
set to 3σ, corresponding to SNR = 3.
Separation of protein signals from noise
We compared multiple spectra to measure the reliability
of the peaks detected in each single spectrum. However,
since the mass spectra could be incompletely aligned after
the calibration procedure, a maximum tolerance distance
d equal to 300 ppm of the m/z value was accepted for the
comparison [15,16]. The information about the peak
intensities was arranged in a [a × b]-dimensional matrix R,
where a is the number of spectra and b the total number
of peaks detected in the mass spectra. Each element rij was
set to zero if the i-th spectrum did not contain the j-th
peak, or otherwise set to the related peak intensity. A b-
dimensional vector z  containing the m/z  values corre-
sponding to the peaks was created. The vector z and the
columns of the matrix R were then sorted in ascending
order on the basis of the m/z value. The matrix dimension
was reduced by replacing the columns of R for which the
elements of z were within the distance d with a unique col-
umn containing their sum. In a similar manner, the same
Multiple-spectra analysis of the peaks detected with LIMPIC Figure 9
Multiple-spectra analysis of the peaks detected with LIMPIC. The results of peak detection rate (PDR) associated with 
all the LIMPIC peak classes are presented for plasma mass spectra, as well as those of signal-to-noise ratio (SNR) of the "true" 
protein peaks, characterized by a PDR larger than or equal to 0.5. (a) For each peak class, the PDR is represented in linear 
scale as a vertical line, which is positioned in correspondence of the related m/z value; (b) Histogram of the PDR values shown 
in (a); (c) For each selected peak class, the SNR is represented in logarithmic scale as a vertical line, which is positioned in cor-
respondence of the related m/z value; (d) Histogram of the average SNR values shown in (c).BMC Bioinformatics 2007, 8:101 http://www.biomedcentral.com/1471-2105/8/101
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values of z within the distance d were substituted with
their average. Several peak classes were created: a peak
detection rate (PDR) was defined as the ratio between the
number of spectra presenting the considered peak and the
total number of analyzed spectra for each class. The peak
classes with a PDR larger than a minimum acceptable PDR
level (generally set between 0.4 and 0.6) were arbitrarily
assumed to be reliable estimates of the protein signals.
When the number of detection errors was relatively low,
this criterion allowed us to characterize the "true" peaks in
the mass spectrum and to classify those remaining as
noise peaks. The selected peak intensities can be used to
generate an average mass spectrum, representative of the
whole group of analyzed MALDI-TOF mass spectra. When
the quantitative analysis of protein peak intensities was
required, as for example in case of biomarker discovery, a
further selection of the "true" peaks should be performed:
following the IUPAC recommendations [14], only the
peaks in the average mass spectrum with SNR > 10 were
retained.
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